期刊
MOVEMENT DISORDERS
卷 24, 期 7, 页码 949-964出版社
WILEY
DOI: 10.1002/mds.22413
关键词
multiple system atrophy; Parkinson; MRI; PET; SPECT
资金
- NIH [1 R13 NS055459]
- Novartis Pharmaceuticals
- Chelsea Therapeutics
- American Academy of Neurology (AAN)
In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated. It is concluded that, although neuroimaging biomarkers provide valuable supportive data along-side clinical assessments, it is not possible to use them as surrogate markers. (C) 2009 Movement Disorders Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据